Adult Influenza Vaccines – Secondary Care

Period of framework agreement: 1 September 2022 to 31 August 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months